News

Derse Strengthens Healthcare Marketing with Jon Ellms' Expertise

Derse Strengthens Healthcare Marketing with Jon Ellms' Expertise

Derse Enhances Leadership in Healthcare Marketing

Derse is taking significant steps to enhance how life sciences brands interact with healthcare professionals, focusing on delivering smarter and strategically crafted experiences. This growth is epitomized by the recent arrival of Jon Ellms, who will serve as Vice President, Client Development – Healthcare.

Welcoming Jon Ellms to Derse

Jon Ellms joins Derse after a remarkable career marked by over 30 years of expertise in healthcare meetings and events. His previous role saw him elevate Access TCA's healthcare practices, gaining recognition within the life sciences sector. As a long-time leader and President-Elect of the Healthcare Convention & Exhibitors Association (HCEA), he offers invaluable insights into the complexities of global congresses and professional engagement.

Significance of Ellms’ Contribution

Ellms' induction into Derse signifies a new phase in the company’s mission to meet the evolving requirements of healthcare marketers, whether they are emerging biotech firms or established industry giants. His wealth of knowledge is set to bolster Derse's already formidable healthcare team as they expand their global reach and impact.

Statements from Leadership

Brett Haney, CEO of Derse, expressed excitement over Ellms joining the team, stating, "Jon's addition reinforces Derse's leadership in healthcare and our commitment to empowering companies in the life sciences. With Jon joining our deep bench of healthcare experts, we're continuing to redefine impactful, compliant, and globally scalable experiences that meet the demands of 21st-century healthcare marketers."

Jon Ellms' Vision for Derse

Upon joining the company, Ellms remarked, "I chose Derse not only for its legendary reputation but also for its investment in innovation and its people. Today's healthcare marketers need experienced teams, improved tools, and deeper insights to cultivate genuine clinical advocacy at congresses. Derse grasps that reality, and I am thrilled to join a team dedicated to enabling clients to realize the true potential of convention and event marketing now and into the future."

About Derse

Located in Milwaukee, Wisconsin, Derse stands as a family-owned experiential marketing agency and exhibit builder, employing nearly 600 individuals across seven full-service divisions in the United States and Europe. For over 75 years, Derse has crafted award-winning exhibits, events, and environments in more than 50 countries, establishing itself as one of the most esteemed companies in the industry. The company's ethos, "Experiences Matter at Derse," highlights its commitment to excellence and innovation within the sector.

Media Contact Information

For additional inquiries, please reach out to Stacey Nelson, VP of Marketing at Derse. For more information, you can contact the office directly or visit their website.

Frequently Asked Questions

1. Who is Jon Ellms?

Jon Ellms is the new Vice President of Client Development - Healthcare at Derse, bringing over 30 years of experience in healthcare meetings and events.

2. What is Derse's focus in the healthcare sector?

Derse focuses on enhancing connections between life sciences brands and healthcare professionals through innovative and strategic marketing solutions.

3. What previous experience does Jon Ellms have?

Before joining Derse, Ellms played a pivotal role in growing Access TCA's healthcare practice and was a leader in the Healthcare Convention & Exhibitors Association.

4. What does Derse aim to achieve with this new leadership?

Derse aims to improve healthcare marketing strategies, offering more effective ways for life sciences companies to engage healthcare professionals.

5. How long has Derse been in operation?

Derse has been in operation for over 75 years, with a strong reputation for creating award-winning marketing experiences worldwide.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Fuse Oncology Showcases New iRT Workflow at ASTRO

Updated Category News Views 4

Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...

Continue Reading
Leo Cancer Care's Upright Radiotherapy Milestone

Updated Category News Views 4

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...

Continue Reading
DKS Facing Class Action Over Stock Slump Allegations

Updated Category News Views 2

A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...

Continue Reading
AI Memory Growth Pushes Limits at GMIF2026 Summit

Updated Category News Views 3

The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...

Continue Reading
Synagro Technologies Faces Lawsuit Over Unpaid Expenses

Updated Category News Views 6

Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...

Continue Reading
IASO's FUCASO Shows Robust Results in 2026 Study

Updated Category News Views 6

IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...

Continue Reading
Melrose Fire Station Reaches Steel Topping Milestone

Updated Category News Views 2

Metal and Milestones: A New Era for Melrose Rolling into Melrose, Massachusetts, there's some serious action kicking off with the new Fire Engine 2 Station reaching a steel topping milestone. This phase isn't just about slapping on another beam; it's the crescendo of diligent teamwork from all the hands involved—from CTA Construction Managers to the clout of Ironworkers...

Continue Reading
Revamping Children's Radiotherapy: Leo Cancer Care's Vision

Updated Category News Views 4

The latest buzz in pediatric radiotherapy is shaking things up, and it’s all thanks to a game-changing shift in how treatment is delivered to kids. We're eyeballing Leo Cancer Care's innovative approach that might just redefine how these young patients face their battles. Standing Tall: A New Chapter in Proton Therapy In June, Stanford Medicine dished out the first...

Continue Reading
Accuray, Samsung Push Boundaries with Imaging Deal

Updated Category News Views 2

In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...

Continue Reading
Quay Shines in 2026 Prescription Sunglasses Lineup

Updated Category News Views 5

Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...

Continue Reading

Top 5 Most Recently Viewed Articles

Sprott Focus Trust Reports Quarterly Distribution and Insights

Updated Category News Views 195

Sprott Focus Trust Announces Quarterly Share Distribution In an uplifting update for investors, Sprott Focus Trust, Inc. (Nasdaq: FUND) has just declared a quarterly distribution of $0.1274 per share on its Common Stock. This distribution offers shareholders a choice between receiving payment in additional shares or cash. Set for disbursement on September 29, 2025,...

Continue Reading
Personal Injury Lawsuits: What You Need to Know Before Filing

Updated Category Personal Finance Views 1165

If you have been injured due to someone else's negligence or careless actions, you may be considering filing a personal injury lawsuit. Consulting a personal injury claim lawyer can help you understand your rights and the complexities involved in pursuing compensation. Personal injury lawsuits can be an effective way to recover damages for medical bills, lost wages, pain...

Continue Reading
Honeywell and Qualcomm Join Forces to Advance AI in Energy Sector

Updated Category News Views 188

Collaborating to Enhance AI Solutions in Energy Honeywell (NASDAQ: HON) and Qualcomm (NASDAQ: QCOM) Technologies, Inc. are making headlines with their groundbreaking collaboration aimed at revolutionizing artificial intelligence (AI) solutions within the energy sector. This partnership is a significant step towards enhancing Honeywell's automation offerings by seamlessly...

Continue Reading
Celebrating Diversity: The Best Gift for Foodies This Season

Updated Category News Views 106

Celebrating the Best Gift for Foodies Packed with Purpose (PwP), a Certified Woman-Owned and B Corp gifting company, has made headlines with its Black-Owned Spotlight Gift Basket, recently awarded as the Best Gift for Foodies. Understanding the Award Recognition This prestigious recognition comes from the USA Today 10Best Readers' Choice Awards, where a dedicated panel of...

Continue Reading
Coloplast A/S Updates Organic Growth and EBIT Margin Guidance

Updated Category News Views 620

Coloplast A/S Adjusts Financial Guidance for FY 2024/25 Coloplast A/S has revised its financial expectations for FY 2024/25, particularly in terms of organic growth and EBIT margin before special items. The anticipated organic growth has been adjusted to approximately 7%, down from the previous expectation of 8-9%. Additionally, the EBIT margin is now projected to be in...

Continue Reading